ASX - By Stock
|
OCC |
Re:
Ann: Ortho-ATI Shoulder Tendon Study Update Revised
|
|
Speckled
|
93 |
23K |
2 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
93
|
23K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Ortho-ATI Shoulder Tendon Study Update Revised
|
|
Speckled
|
93 |
23K |
6 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
93
|
23K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Positive Data for CelGro Collagen Rope in ACL Reconstruction
|
|
Speckled
|
48 |
11K |
0 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
48
|
11K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Positive Data for CelGro Collagen Rope in ACL Reconstruction
|
|
Speckled
|
48 |
11K |
6 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
48
|
11K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Positive Data for CelGro Collagen Rope in ACL Reconstruction
|
|
Speckled
|
48 |
11K |
0 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
48
|
11K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Positive Data for CelGro Collagen Rope in ACL Reconstruction
|
|
Speckled
|
48 |
11K |
10 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
48
|
11K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
FDA significance
|
|
Speckled
|
502 |
302K |
1 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
502
|
302K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Secures Patents for Suture-Less Repair of Soft Tissue
|
|
Speckled
|
29 |
8.9K |
2 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
29
|
8.9K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
J&J Partnership
|
|
Speckled
|
402 |
284K |
3 |
11/09/21 |
11/09/21 |
ASX - By Stock
|
402
|
284K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Secures Patents for Suture-Less Repair of Soft Tissue
|
|
Speckled
|
29 |
8.9K |
2 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
29
|
8.9K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Secures Patents for Suture-Less Repair of Soft Tissue
|
|
Speckled
|
29 |
8.9K |
5 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
29
|
8.9K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
Speckled
|
2.0K |
1.0M |
6 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
2.0K
|
1.0M
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Proactive Investors Interview with Orthocells MD
|
|
Speckled
|
43 |
9.3K |
4 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
43
|
9.3K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Proactive Investors Interview with Orthocells MD
|
|
Speckled
|
43 |
9.3K |
1 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
43
|
9.3K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Proactive Investors Interview with Orthocells MD
|
|
Speckled
|
43 |
9.3K |
1 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
43
|
9.3K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
2 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
1.6K
|
492K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Ortho-ATI Shoulder Tendon Study Update Revised
|
|
Speckled
|
93 |
23K |
11 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
93
|
23K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
Speckled
|
458 |
152K |
6 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
458
|
152K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
Speckled
|
59 |
12K |
8 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
59
|
12K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
0 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
218
|
68K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
2 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
218
|
68K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
Speckled
|
59 |
12K |
3 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
59
|
12K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
2 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
218
|
68K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
3 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
218
|
68K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
5 |
22/08/21 |
22/08/21 |
ASX - By Stock
|
218
|
68K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Application for quotation of securities - OCC
|
|
Speckled
|
20 |
5.5K |
9 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
20
|
5.5K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Application for quotation of securities - OCC
|
|
Speckled
|
20 |
5.5K |
1 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
20
|
5.5K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
4 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
218
|
68K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
3 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
218
|
68K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
12 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
218
|
68K
|
12
|
|
ASX - By Stock
|
OCC |
Re:
FDA significance
|
|
Speckled
|
502 |
302K |
1 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
502
|
302K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
FDA significance
|
|
Speckled
|
502 |
302K |
4 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
502
|
302K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
FDA significance
|
|
Speckled
|
502 |
302K |
3 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
502
|
302K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Appoints Exclusive Distributor in Australia
|
|
Speckled
|
69 |
19K |
9 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
69
|
19K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
FDA significance
|
|
Speckled
|
502 |
302K |
1 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
502
|
302K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
Speckled
|
458 |
152K |
7 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
458
|
152K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Appoints Exclusive Distributor in Australia
|
|
Speckled
|
69 |
19K |
12 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
69
|
19K
|
12
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Appoints Exclusive Distributor in Australia
|
|
Speckled
|
69 |
19K |
5 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
69
|
19K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
1 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
1.6K
|
492K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
|
|
Speckled
|
218 |
68K |
5 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
218
|
68K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
How does Celgro Nerve compare?
|
|
Speckled
|
5 |
2.3K |
10 |
27/06/21 |
27/06/21 |
ASX - By Stock
|
5
|
2.3K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Positive CelGro Nerve Regeneration Results
|
|
Speckled
|
79 |
22K |
2 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
79
|
22K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
1 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
1.6K
|
492K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
6 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
1.6K
|
492K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
6 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
1.6K
|
492K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
1 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
1.6K
|
492K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
2 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
1.6K
|
492K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
1 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
1.6K
|
492K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.6K |
492K |
2 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
1.6K
|
492K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Secures Patents for Sutureless Repair of Soft Tissue
|
|
Speckled
|
13 |
4.9K |
9 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
13
|
4.9K
|
9
|
|